These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Toth C; Rong LL; Yang C; Martinez J; Song F; Ramji N; Brussee V; Liu W; Durand J; Nguyen MD; Schmidt AM; Zochodne DW Diabetes; 2008 Apr; 57(4):1002-17. PubMed ID: 18039814 [TBL] [Abstract][Full Text] [Related]
25. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Obrosova IG; Drel VR; Pacher P; Ilnytska O; Wang ZQ; Stevens MJ; Yorek MA Diabetes; 2005 Dec; 54(12):3435-41. PubMed ID: 16306359 [TBL] [Abstract][Full Text] [Related]
26. Prevention of neural tube defects by loss of function of inducible nitric oxide synthase in fetuses of a mouse model of streptozotocin-induced diabetes. Sugimura Y; Murase T; Oyama K; Uchida A; Sato N; Hayasaka S; Kano Y; Takagishi Y; Hayashi Y; Oiso Y; Murata Y Diabetologia; 2009 May; 52(5):962-71. PubMed ID: 19283362 [TBL] [Abstract][Full Text] [Related]
27. MiR-106a Associated with Diabetic Peripheral Neuropathy Through the Regulation of 12/15-LOX-meidiated Oxidative/Nitrative Stress. Wu Y; Xu D; Zhu X; Yang G; Ren M Curr Neurovasc Res; 2017; 14(2):117-124. PubMed ID: 28393703 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of a long-acting C-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice. Jolivalt CG; Rodriguez M; Wahren J; Calcutt NA Diabetes Obes Metab; 2015 Aug; 17(8):781-8. PubMed ID: 25904006 [TBL] [Abstract][Full Text] [Related]
29. Na+/H+ exchanger 1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats. Lupachyk S; Watcho P; Shevalye H; Vareniuk I; Obrosov A; Obrosova IG; Yorek MA Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E396-404. PubMed ID: 23736542 [TBL] [Abstract][Full Text] [Related]
33. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Kellogg AP; Wiggin TD; Larkin DD; Hayes JM; Stevens MJ; Pop-Busui R Diabetes; 2007 Dec; 56(12):2997-3005. PubMed ID: 17720896 [TBL] [Abstract][Full Text] [Related]
34. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy. Arora M; Kumar A; Kaundal RK; Sharma SS Eur J Pharmacol; 2008 Oct; 596(1-3):77-83. PubMed ID: 18768138 [TBL] [Abstract][Full Text] [Related]
35. Lidocaine attenuates the development of diabetic-induced tactile allodynia by inhibiting microglial activation. Suzuki N; Hasegawa-Moriyama M; Takahashi Y; Kamikubo Y; Sakurai T; Inada E Anesth Analg; 2011 Oct; 113(4):941-6. PubMed ID: 21788310 [TBL] [Abstract][Full Text] [Related]
36. Wld(S) protects against peripheral neuropathy and retinopathy in an experimental model of diabetes in mice. Zhu SS; Ren Y; Zhang M; Cao JQ; Yang Q; Li XY; Bai H; Jiang L; Jiang Q; He ZG; Chen Q Diabetologia; 2011 Sep; 54(9):2440-50. PubMed ID: 21739347 [TBL] [Abstract][Full Text] [Related]
37. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Ii M; Nishimura H; Kusano KF; Qin G; Yoon YS; Wecker A; Asahara T; Losordo DW Circulation; 2005 Jul; 112(1):93-102. PubMed ID: 15983249 [TBL] [Abstract][Full Text] [Related]
40. Peroxynitrite plays a key role in glomerular lesions in diabetic rats. Xiao H; Li Y; Qi J; Wang H; Liu K J Nephrol; 2009; 22(6):800-8. PubMed ID: 19967660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]